|
[1] ZUO L, ZHOU T, PANNELL BK, et al. Biological and physiological role of reactive oxygen species-the good, the bad and the ugly[J]. Acta Physiol (Oxf) , 2015, 214 (3) :329-348.
|
|
[2] LI S, TAN HY, WANG N, et al. The role of oxidative stress and antioxidants in liver diseases[J]. Int J Mol Sci, 2015, 16 (11) :26087-26124.
|
|
[3] LI S, HONG M, TAN HY, et al. Insights into the role and interdependence of oxidative stress and inflammation in liver diseases[J]. Oxid Med Cell Longev, 2016, 2016:4234061.
|
|
[4] LUANGMONKONG T. Targeting oxidative stress for the treatment of liver fibrosis[J]. Rev Physiol Biochem Pharmacol, 2018, 175:71-102.
|
|
[5] SINGAL AK, JAMPANA SC, WEINMAN SA, et al. Antioxidants as therapeutic agents for liver disease[J]. Liver Int, 2011, 31 (10) :1432-1448.
|
|
[6] URTASUN R, ROSA CDL, NIETO N, et al. Oxidative and nitrosative stress and fibrogenic response[J]. Clin Liver Dis, 2008, 12 (4) :769-790.
|
|
[7] LIN W, TSAI WL, SHAO RX, et al. Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaBdependent manner[J]. Gastroenterology, 2010, 138 (7) :2509-2518.
|
|
[8] SHA J, ZHANG H, ZHAO Y, et al. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3beta/MKP-1/Nrf2pathway activity via the alpha2 adrenergic receptor[J]. Toxicol Appl Pharmacol, 2018, 364:144-152.
|
|
[9] FARR SA, RIPLEY JL, SULTANA R, et al. Antisense oligonucleotide against GSK-3beta in brain of SAMP8 mice improves learning and memory and decreases oxidative stress:Involvement of transcription factor Nrf2 and implications for Alzheimer disease[J]. Free Radic Biol Med, 2014, 67:387-395.
|
|
[10] BATALLER R, BRENNER DA. Liver fibrosis[J]. J Clin Invest, 2005, 115 (2) :209-218.
|
|
[11] PAROLA M, PINZANI M. Liver fibrosis:Pathophysiology, pathogenetic targets and clinical issues[J]. Mol Aspects Med, 2019, 65:37-55.
|
|
[12] SUN M, KISSELEVA T. Reversibility of liver fibrosis[J]. Clin Res Hepatol Gastroenterol, 2015, 39 (Suppl 1) :s60-s63.
|
|
[13] AYDIN MM, AKCALI KC. Liver fibrosis[J]. Turk J Gastroenterol, 2018, 29 (1) :14-21.
|
|
[14] ZHANG CY, YUAN WG, HE P, et al. Liver fibrosis and hepatic stellate cells:Etiology, pathological hallmarks and therapeutic targets[J]. World J Gastroenterol, 2016, 22 (48) :10512-10522.
|
|
[15] KURDI A, HASSAN K, VENKATARAMAN B, et al. Nootkatone confers hepatoprotective and anti-fibrotic actions in a murine model of liver fibrosis by suppressing oxidative stress, inflammation, and apoptosis[J]. J Biochem Mol Toxicol, 2018, 32 (7) :e22017.
|
|
[16] ATALLAH MAA, ELAIDY SM, TAWFIK MK, et al. Assessment of the possible roles of SB-269970 versus ketanserin on carbon tetrachloride-induced liver fibrosis in rats:Oxidative stress/TGF-beta1-induced HSCs activation pathway[J].Pharmacol Rep, 2018, 70 (3) :509-518.
|
|
[17] WANG X. Gliptins suppress inflammatory macrophage activation to mitigate inflammation, fibrosis, oxidative stress, and vascular dysfunction in models of nonalcoholic steatohepatitis and liver fibrosis[J]. Antioxid Redox Signal, 2018, 28 (2) :87-109.
|
|
[18] ALTENHOFER S, RADERMACHER KA, KLEIKERS PW, et al.Evolution of NADPH oxidase inhibitors:Selectivity and mechanisms for target engagement[J]. Antioxid Redox Signal, 2015, 23 (5) :406-427.
|
|
[19] MORTEZAEE K. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis:A review[J].Cell Biochem Funct, 2018, 36 (6) :292-302.
|
|
[20] HUANG J. Adoptive transfer of heme oxygenase-1 (HO-1) -modified macrophages rescues the nuclear factor erythroid 2-related factor (Nrf2) antiinflammatory phenotype in liver ischemia/reperfusion injury[J]. Mol Med, 2014, 20:448-455.
|
|
[21] JIANG JX. Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo[J]. Gastroenterology, 2010, 139 (4) :1375-1384.
|
|
[22] DIXON LJ, BARNES M, TANG H, et al. Kupffer cells in the liver[J]. Compr Physiol, 2013, 3 (2) :785-797.
|
|
[23] JIANG JX. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo[J]. Free Radic Biol Med, 2012, 53 (2) :289-296.
|
|
[24] SANCHO P. NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development[J]. PLo S One, 2012, 7 (9) :e45285.
|
|
[25] BISWAS SK. Does the Interdependence between oxidative stress and inflammation explain the antioxidant paradox?[J]. Oxid Med Cell Longev, 2016, 2016:5698931.
|
|
[26] AMBADE A, MANDREKAR P. Oxidative stress and inflammation:Essential partners in alcoholic liver disease[J]. Int J Hepatol, 2012, 2012:853175.
|
|
[27] SNCHEZ-VALLE V, CHVEZ-TAPIA NC, MNDEZ-SNCHEZ N, et al. Role of oxidative stress and molecular changes in liver fibrosis:A review[J]. Curr Med Chem, 2012, 19:4850-4860.
|
|
[28] SUN J. Anthocyanins isolated from blueberry ameliorates CCl4induced liver fibrosis by modulation of oxidative stress, inflammation and stellate cell activation in mice[J]. Food Chem Toxicol, 2018, 120:491-499.
|
|
[29] SANCHETI S, SEO SY. Ameliorative effects of 7-methylcoumarin and 7-methoxycoumarin against CCl4-induced hepatotoxicity in rats[J]. Drug Chem Toxicol, 2013, 36 (1) :42-47.
|
|
[30] LI J. Reactive oxygen species released from hypoxic hepatocytes regulates MMP-2 expression in hepatic stellate cells[J]. Int J Mol Sci, 2011, 12 (4) :2434-2447.
|
|
[31] MENG N, XIA M, LU YQ, et al. Activation of NLRP3 inflammasomes in mouse hepatic stellate cells during Schistosoma J.infection[J]. Oncotarget, 2016, 7 (26) :39316-39331.
|
|
[32] SCHWABE RF, LUEDDE T. Apoptosis and necroptosis in the liver:A matter of life and death[J]. Nat Rev Gastroenterol Hepatol, 2018, 15 (12) :738-752.
|
|
[33] DA SILVA BDO, RAMOS LF, MORAES KCM. Molecular interplays in hepatic stellate cells:Apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis[J]. Cell Biol Int, 2017, 41 (9) :946-959.
|
|
[34] WANG K. Autophagy and apoptosis in liver injury[J]. Cell Cycle, 2015, 14 (11) :1631-1642.
|
|
[35] WANG K. Molecular mechanisms of hepatic apoptosis[J].Cell Death Dis, 2014, 5:e996.
|
|
[36] KONDO Y, ISHIGAMI A. Involvement of senescence marker protein-30 in glucose metabolism disorder and non-alcoholic fatty liver disease[J]. Geriatr Gerontol Int, 2016, 16 (Suppl1) :4-16.
|
|
[37] HU SJ, JIANG SS, ZHANG J, et al. Effects of apoptosis on liver aging[J]. World J Clin Cases, 2019, 7 (6) :691-704.
|
|
[38] MEYER JN, LEUTHNER TC, LUZ AL. Mitochondrial fusion, fission, and mitochondrial toxicity[J]. Toxicology, 2017, 391:42-53.
|
|
[39] MATSUMOTO N, EZAKI J, KOMATSU M, et al. Comprehensive proteomics analysis of autophagy-deficient mouse liver[J]. Biochem Biophys Res Commun, 2008, 368 (3) :643-649.
|
|
[40] STANKOV, MV. Autophagy inhibition due to thymidine analogues as novel mechanism leading to hepatocyte dysfunction and lipid accumulation[J]. AIDS, 2012, 26 (16) :1995-2006.
|
|
[41] LEVONEN AL, HILL BG, KANSANEN E, et al. Redox regulation of antioxidants, autophagy, and the response to stress:Implications for electrophile therapeutics[J]. Free Radic Biol Med, 2014, 71:196-207.
|
|
[42] FILOMENI G, de ZIO D, CECCONI F, et al. Oxidative stress and autophagy:The clash between damage and metabolic needs[J]. Cell Death Differ, 2015, 22 (3) :377-388.
|
|
[43] RUART M. Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury[J]. J Hepatol, 2019, 70 (3) :458-469.
|
|
[44] SHIN SM, YANG JH, KI SH. Role of the Nrf2-ARE pathway in liver diseases[J]. Oxid Med Cell Longev, 2013, 2013:763257.
|
|
[45] JADEJA RN, UPADHYAY KK, DEVKAR RV. Naturally occurring Nrf2 activators:Potential in treatment of liver injury[J].Oxid Med Cell Longev, 2016, 2016:3453926.
|
|
[46] YANG JH. Bamboo stems (phyllostachys nigra variety henosis) containing polyphenol mixtures activate Nrf2 and attenuate phenylhydrazine-induced oxidative stress and liver injury[J]. Nutrients, 2019, 11 (1) :e114.
|
|
[47] GU L. Ellagic acid protects lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice[J]. Int Immunopharmacol, 2014, 22 (2) :341-345.
|
|
[48] NI HM. Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy[J]. J Hepatol, 2014, 61 (3) :617-625.
|
|
[49] CANNITO S, NOVO E, PAROLA M. Therapeutic pro-fibrogenic signaling pathways in fibroblasts[J]. Adv Drug Deliv Rev, 2017, 121:57-84.
|
|
[50] LI S, HONG M, TAN HY, et al. Insights into the role and interdependence of oxidative stressand inflammation in liver diseases[J]. Oxid Med Cell Longev, 2016, 2016:4234061.
|
|
[51] YANG JH, KIM SC, KIM KM, et al. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress[J]. Eur J Pharmacol, 2016, 783:92-102.
|
|
[52] AFRIN R, ARUMUGAM, RAHMAN A, et al. Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation[J]. Int Immunopharmacol, 2017, 44:174-182.
|
|
[53] MITCHELL S, VARGAS J, HOFFMANN A. Signaling via the NFkappaB system[J]. Wiley Interdiscip Rev Syst Biol Med, 2016, 8 (3) :227-241.
|
|
[54] BUBICI C, PAPA S, PHAM CG, et al. The NF-kappaB-mediated control of ROS and JNK signaling[J]. Histol Histopathol, 2006, 21 (1) :69-80.
|
|
[55] HUSAIN H, LATIEF U, AHMAD R. Pomegranate action in curbing the incidence of liver injury triggered by Diethylnitrosamine by declining oxidative stress via Nrf2 and NFkappaB regulation[J]. Sci Rep, 2018, 8 (1) :8606.
|
|
[56] SHI H, SHI A, DONG L, et al. Chlorogenic acid protects against liver fibrosis in vivo and in vitro through inhibition of oxidative stress[J]. Clin Nutr, 2016, 35 (6) :1366-1373.
|
|
[57] TAO GZ, LEHWALD N, JANG KY, et al. Wnt/β-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3[J]. J Biol Chem, 2013, 288 (24) :17214-17224.
|
DownLoad: